JP2000197578A - Manufacture of wet tissue having antibacterial and mildew resistant effect - Google Patents

Abstract

PROBLEM TO BE SOLVED: To prevent mildew from growing during the preservation period, from manufacturing to use, by a method wherein in imazalil or a mixture of imazalil and a cationic antibacterial agent and/or amphoteric antibacterial agent is applied to a wet tissue prepared by using a paper or non-woven fabric. SOLUTION: A processed chemical prepared by properly mixing a cationic antibacterial agent, amphoteric antibacterial agent or imazalil of 150-250 wt.% is sprayed on or impregnated into raw fabrics of wet tissue. Thus, mildew is prevented from growing during the preservation period of the wet tissue, and hence sanitary wet tissues can be manufactured.

Description

DETAILED DESCRIPTION OF THE INVENTION

[0001]

The present invention relates to a raw antibacterial agent such as imazalil or imazalil and benzalkonium chloride for wet tissue such as paper and non-woven fabric;
Or, a wet tissue production method in which an antibacterial agent in a formulation formulated with an amphoteric antibacterial agent is diluted with water and treated.

[0002] Further processed wet tissue has not only the usual washing and disinfecting effects, but also the ability to prevent the occurrence of mold during the storage period.

[0003]

2. Description of the Prior Art Catalytic antibacterial agents, amphoteric antibacterial agents, preservatives such as parabens, benzoic acid, etc., alcohols, polyhydric alcohols such as propylene glycol, etc. are processed in large quantities in wet tissues. Have been.

[0004] These are used for cleaning parts to be used,
It is effective in removing bacteria, but because it is treated with a large amount of water, it is less effective against mold.
Mold often occurs during the storage period.

[0005]

SUMMARY OF THE INVENTION The present invention improves the preservability of a conventional wet tissue and reduces the amount of a cationic substance such as benzalkonium chloride to reduce the metal corrosiveness of a cationic antibacterial agent. The purpose is to suppress skin irritation.

[0006]

According to the present invention, the use of imazalil is effective against fungi which cannot be suppressed by conventional benzalkonium chloride alone.

[0007] A major feature of the present invention is that the use of imazalil improves the antifungal effect and further reduces the amount of benzalkonium chloride to be added. It is to suppress skin irritation.

[0008] As the original function of wet tissue,
As antibacterial agents, cationic antibacterial agents having a quaternary ammonium salt structure such as benzalkonium chloride, benzethonium chloride, and cetylpyridinium chloride, and alkylglycine-type amphoteric antibacterial agents are used.

As preservatives for the purpose of preserving the wet tissue itself, benzoic acid, benzoates, and paraoxybenzoates (alkyl is C ₁ -C ₄ ) are used.

[0010] The imazalil of the present invention is
When the compounding amount is 0.01 to 0.2, an antifungal effect is exhibited.
However, it is not limited to this blending amount.

The composition used in the present invention is desirably one listed in the standard of food additive or cosmetic raw material in consideration of safety.

The processing method is based on the weight of the paper to be processed and the nonwoven fabric or the like (hereinafter, referred to as raw material) in a range of 150 to 250.
% Of the working fluid by spraying or impregnation.
However, the appropriate amount of processing differs depending on the material to be processed.

[0013] In addition to the composition of the present invention, components such as fragrances and coloring agents can be blended.

[0014]

The wet tissue processing composition of the present invention is a composition containing imazalil, a cationic antibacterial agent, and an amphoteric antibacterial agent, and is used for wiping the skin.

[0015]

The present invention will be described below in detail with reference to examples. However, the invention is not limited to these examples.

(Embodiment 1) Used in the embodiment of the present invention,
Table 1 shows formulation examples of imazalil, cationic antibacterial agents, amphoteric antibacterial agents, preservatives and the like.

The nonwoven fabric was treated with the compounding agents shown in Table 1 without unevenness by 200% based on the weight of the nonwoven fabric. An antibacterial and antifungal test was performed on this wet tissue. As a comparison, one processed only with water was tested. The results of this test are shown in Table 2.

Test method According to JIS L-1902, an antibacterial test for textile products. According to JIS Z-2911 mold resistance test. Test bacteria ・ Escherichia coli IFO 330
1 (E. coli) Staphylococcus aureus AT
CC 6538P (Staphylococcus) Test mold JIS Z-2911 Mold resistance test Fiber test designated fiber mold. Aspergillus niger FERM
S-1. Penicillium citrinum FE
RM S-5 Chaetomium globosum FERM
S-11 Myrotheium verrucaria FE
RM S-13 A mixture of three or more

Judgment method Bacteria ‥‥ effect (-) no effect (+) Mold ... JIS Z-2911 Mold resistance test By the display method 3 な し No growth of mold on the sample Number 2 ‥‥ The growth area of the mold on the sample is 1/3 or less of the whole 1 ‥‥ 〃 〃 〃 以上 1/3 or more

[0020]

[Table 1]

Chemicals used Compound A: Benzalkonium chloride (Cation F2-50, Nippon Oil & Fats Co., Ltd.) Compound B: Methyl parahydroxybenzoate (Ueno Pharmaceutical Co., Ltd.) Compound C: Imazalil (Jansen Co., Ltd.) Compound D: Alkylaminoethyl glycine Na salt (Sanyo Chemical Industries, Ltd.) Compound E: propylene glycol (Showa Denko KK)

[0022]

[Table 2]

[0023]

As described above, the wet tissue processed with imazalil exhibits excellent antibacterial and antifungal effects.

──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. ⁷ Identification symbol FI Theme coat ゛ (Reference) D21H 21/36 D21H 21/36 // A01N 43/50 A01N 43/50 B

Claims (1)

[Claims] 1. 1- [2- (2,4-dichlorophenyl) -2- (2-propenyloxy) ethyl] -1H
-A method for producing a wet tissue having an antibacterial and antifungal effect by blending a cationic antibacterial agent such as imidazole (hereinafter referred to as imazalil) or benzalkonium chloride or an amphoteric antibacterial agent.